PL4252857T3
Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (pcsk9)
Abstract
This record has no abstract on file.
Term
6 yearsto projected expiry
Projected expiry 12 September 2032, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
55 members in 27 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 201161535392 | United States of America | P | |
| 201161559162 | United States of America | P | |
| 201261641321 | United States of America | P |
Members55
| Document | Office | Kind | |
|---|---|---|---|
| CA2848201A1 | Canada | A1 | |
| WO2013039969A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW201329099A | Taiwan Province of China | A | |
| US2013243784A1 | United States of America | A1 | |
| AU2012308797A1 | Australia | A1 | |
| CO6910163A2 | Colombia | A2 | |
| IL231011A0 | Israel | A0 | |
| IL231011D0 | Israel | D0 | |
| PH12014500342A1 | Philippines | A1 | |
| AR087881A1 | Argentina | A1 | |
| MX2014002158A | Mexico | A | |
| KR20140075728A | Republic of Korea | A | |
| SG2014010524A | Singapore | A | |
| EA201490641A1 | Eurasian Patent Organization (EAPO) | A1 | |
| CN103930444A | China | A | |
| EP2756004A1 | European Patent Office (EPO) | A1 | |
| CL2014000605A1 | Chile | A1 | |
| MA35430B1 | Morocco | B1 | |
| JP2014527967A | Japan | A | |
| ZA201401114B | South Africa | B | |
| NZ621135A | New Zealand | A | |
| BR112014005522A2 | Brazil | A2 | |
| AU2012308797B2 | Australia | B2 | |
| JP6158813B2 | Japan | B2 | |
| TWI601740B | Taiwan Province of China | B | |
| EA028278B1 | Eurasian Patent Organization (EAPO) | B1 | |
| JP2017206520A | Japan | A | |
| US10076571B2 | United States of America | B2 | |
| US2018333490A1 | United States of America | A1 | |
| MX363642B | Mexico | B | |
| KR101964031B1 | Republic of Korea | B1 | |
| PH12014500342B1 | Philippines | B1 | |
| MY170089A | Malaysia | A | |
| EP3536712A1 | European Patent Office (EPO) | A1 | |
| EP2756004B1 | European Patent Office (EPO) | B1 | |
| IL231011A | Israel | A | |
| IL231011B | Israel | B | |
| ES2773111T3 | Spain | T3 | |
| CN103930444B | China | B | |
| CN111789944A | China | A | |
| CA2848201C | Canada | C | |
| US11116839B2 | United States of America | B2 | |
| EP3536712B1 | European Patent Office (EPO) | B1 | |
| EP4252857A2 | European Patent Office (EPO) | A2 | |
| ES2953713T3 | Spain | T3 | |
| EP4252857A3 | European Patent Office (EPO) | A3 | |
| EP4252857B1 | European Patent Office (EPO) | B1 | |
| EP4252857C0 | European Patent Office (EPO) | C0 | |
| EP4461373A2 | European Patent Office (EPO) | A2 | |
| ES2992345T3 | Spain | T3 | |
| HRP20241450T1 | Croatia | T1 | |
| EP4461373A3 | European Patent Office (EPO) | A3 | |
| RS66342B1 | Serbia | B1 | |
| HUE069234T2 | Hungary | T2 | |
| PL4252857T3This record | Poland | T3 |
Numbers
- Publication
- 4252857
- Application
- 23176223
Titles2
- English
- METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)
- Polish
- SPOSOBY REDUKOWANIA POZIOMÓW LIPOPROTEINY(A) POPRZEZ PODAWANIE INHIBITORA PROPROTEINOWEJ KONWERTAZY SUBTYLIZYNY KEKSYNY-9 (PCSK9)
Classification
- CPC, 12
- C07K16/40
- A61K39/3955
- A61K2039/505
- A61P11/00
- A61P27/02
- A61P3/06
- A61P43/00
- A61P7/00
- A61P9/00
- A61P9/10
- C07K2317/21
- C07K2317/76
- IPC, 9
- C07K16 40
- A61K39 00
- A61P3 06
- A61P7 00
- A61P9 00
- A61P9 10
- A61P11 00
- A61P27 02
- A61P43 00